First Trial Launches to Test Effectiveness of Male Contraceptive Gel

NES/T is a novel, reversible contraceptive for men designed to be absorbed through the skin.

FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control

FDA approval marks an important step toward expanding contraceptive options for women.

Population Council Announces New License Agreement

New agreement will make the Council's one-year vaginal system for contraception available to women in the US.

First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials

If proven effective, PC-1005 gel would be the first product to prevent three incurable STIs—HIV, HSV, and HPV.

Population Council Advances Non-Antiretroviral Multipurpose Prevention Technology For HIV and STI Prevention to Clinical Trial

First in-human clinical trial of griffithsin, a naturally occurring anti-HIV protein, which limits risk of cross-resistance to antiretroviral (ARV) products.

Population Council Awarded Breakthrough-RESEARCH Project by USAID

The project aims to improve healthy behaviors and norms across key global health areas.

New GIRL Center to Shape Research and Investments on What Works to Improve Girls’ Lives

The Council launches the Girl Innovation, Research, and Learning (GIRL) Center.